Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 10:16:1541203.
doi: 10.3389/fimmu.2025.1541203. eCollection 2025.

Development and validation of identification algorithms for five autoimmune diseases using electronic health records: a retrospective cohort study in China

Junting Yang  1   2 , Yunxiao Wu  1   2 , Jinxin Guo  1   2 , Xiaoxuan Wang  1   2 , Xin Gao  1   2 , Xin Chen  1   2 , Mengdi Zhang  1   2 , Jin Yang  3 , Zuojing Liu  4 , Yan Liu  5 , Zhike Liu  1   2 , Siyan Zhan  1   2   6   7
Affiliations

Development and validation of identification algorithms for five autoimmune diseases using electronic health records: a retrospective cohort study in China

Junting Yang et al. Front Immunol. .

Abstract

Objective: This study aims to assess the identification algorithms for five autoimmune diseases-Hashimoto's thyroiditis, inflammatory bowel disease (IBD), primary immune thrombocytopenia (ITP), rheumatoid arthritis (RA), and type 1 diabetes (T1D)-using the Yinzhou Regional Health Information Platform (YRHIP) in China.

Methods: Diagnostic data was extracted from YRHIP's population registry (2010-2021), combining ICD-10 codes and Chinese medical terminology from outpatient, inpatient, and discharge records. Algorithms were validated through chart reviews, adhering to global clinical guidelines. Cases were adjudicated using electronic case report forms. We evaluated algorithm performance based on sensitivity and positive predictive value (PPV), with a 70% PPV threshold for optimization.

Results: Among all reviewed cases, we identified 136 cases for Hashimoto's thyroiditis, 65 for IBD, 76 for ITP, 130 for RA, and 43 for T1D. Algorithm performance varied across diseases: the final algorithm for Hashimoto's thyroiditis achieved optimal accuracy (sensitivity 97.44%, PPV 98.28%), followed by RA (sensitivity 100.00%, PPV 76.92%). Algorithms for IBD and ITP required synthesis of multiple data sources to achieve acceptable performance (IBD: sensitivity 79.66%, PPV 70.15%; ITP: sensitivity 62.50%, PPV 70.00%). For T1D, the final algorithm utilizing both admission and outpatient records yielded satisfactory results (sensitivity 84.09%, PPV 74.00%).

Conclusions: This study presents the first validated algorithms for identifying autoimmune diseases using EHR data in China, demonstrating satisfactory performance (PPV >70%) across all diseases. Our findings demonstrate that a combination of data sources is crucial for accurate case identification in complex autoimmune conditions, providing an important methodological foundation for future real-world studies in Chinese populations.

Keywords: Hashimoto's thyroiditis; algorithms; computable phenotype; electronic health records (EHR); inflammatory bowel disease (IBD); primary immune thrombocytopenia; rheumatoid arthritis (RA); type 1 diabetes (T1D).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

References

    1. Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. (2023) 80:102266. doi: 10.1016/j.coi.2022.102266 - DOI - PMC - PubMed
    1. Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. (2015) 278:369–95. doi: 10.1111/joim.2015.278.issue-4 - DOI - PubMed
    1. Cao F, He YS, Wang Y, Zha CK, Lu JM, Tao LM, et al. . Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019. Autoimmun Rev. (2023) 22:103326. doi: 10.1016/j.autrev.2023.103326 - DOI - PubMed
    1. Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, et al. . Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. (2023) 401:1878–90. doi: 10.1016/S0140-6736(23)00457-9 - DOI - PubMed
    1. Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. . Real-world evidence - what is it and what can it tell us? New Engl J Med. (2016) 375:2293–7. doi: 10.1056/NEJMsb1609216 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources